ANAtsushi Nakayama

Atsushi Nakayama

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Atsushi Nakayama has a total of 152 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Short- and long-term outcomes of underwater versus conventional colorectal endoscopic submucosal dissection: a large retrospective real-world cohort study

    by Shoma Murata, Teppei Masunaga, Motoki Sasaki, Mai Owada, Ai Katsumi, Maya Ishizawa, Yuki Kubo, Rei Mizobe, Yuri Imura, Anna Tojo, et al.

    Underwater techniques are increasingly used in colorectal endoscopic submucosal dissection (ESD), but real-world data remain limited. We compared underwater and conventional colorectal ESD. This retrospective observational study included consecutive colorectal ESD lesions at a tertiary referral center between May 2010 and September 2024. The analysis used propensity score overlap weighting. Procedural outcomes included dissection speed, procedure time, resection outcomes, and adverse events. Intraoperative perforation and long-term outcomes were assessed descriptively. Among 1649 lesions, 1635 were included in the main analysis (conventional 914, underwater 721). Dissection speed was faster in the underwater group (speed ratio 1.23, 95%CI 1.14 to 1.32; P < 0.001), whereas procedure time was similar. Failure to complete ESD was less frequent in the underwater group, with no clear differences in en bloc resection, R0 resection, or adverse events. Among 56 intraoperative perforation cases, all perforation sites were closed endoscopically, no emergency surgery was required, and short-term clinical outcomes showed no clear differences. Median (interquartile range) survival follow-up was 3.09 (0.48–7.39) and 2.10 (0.56–3.72) years in the conventional and underwater groups, respectively; overall death occurred in 27/824 (3.3%) and 3/622 (0.5%) patients, with no colorectal cancer-related deaths. The underwater technique was associated with faster dissection speed, although this did not translate into a shorter procedure time or clear improvements in other procedural outcomes. These findings suggest a potential technical advantage during dissection, while its clinical relevance remains to be established.


  • Open Access

    Diagnostic Performance and Reproducibility of Chromoendoscopic Classification ( FOCUS Classification: Flat‐Type Dysplasia Optical Assessment by Chromoendoscopy in Ulcerative ColitiS ) for Flat‐Type Dysplasia in Ulcerative Colitis–Associated Neoplasia

    by Kaoru Takabayashi, Shoma Murata, Motoki Sasaki, Kurato Miyazaki, Teppei Masunaga, Kumiko Kirita, Mari Mizutani, Yusuke Yoshimatsu, Yusaku Takatori, Teppei Akimoto, et al.

    Objectives: Ulcerative colitis‐associated neoplasia (UCAN) often presents as flat‐type dysplasia that is difficult to characterize endoscopically. We developed a FOCUS (Flat‐type dysplasia Optical assessment by Chromoendoscopy in Ulcerative colitiS) classification and evaluated its diagnostic performance and reproducibility. Methods: This single‐center retrospective study included 33 UCAN lesions from 26 patients. Prospectively recorded FOCUS classifications at 230 biopsy sites were compared with histopathology. Chromoendoscopic patterns were categorized as Type I (“suggestive of non‐dysplasia,”), Type II (“suggestive of dysplasia with low confidence”), or Type III (“suggestive of dysplasia with high confidence”). Diagnostic performance was assessed using two prespecified thresholds: Types II/III versus Type I and Type III versus Types I/II. Eight endoscopists independently classified all images; interobserver and intraobserver agreement were assessed using Fleiss' and Cohen's κ , respectively. Results: The dysplasia‐bearing rate increased stepwise from Type I to Type III (Type I 15.5%, Type II 58.3%, Type III 81.8%). Using the primary threshold, sensitivity was 82.0%, and specificity 75.4% (positive likelihood ratio 3.33; negative likelihood ratio 0.24). Interobserver agreement for the three‐category classification was moderate to substantial (Fleiss' κ 0.629; 95% CI 0.545–0.712), and median intraobserver agreement was substantial (Cohen's κ 0.738). Conclusions: The FOCUS classification provides clinically meaningful risk stratification for flat‐type dysplasia in a high‐risk UCAN cohort, with acceptable interobserver and intraobserver reproducibility.

  • Clinical outcomes and risk factors for local residual/recurrent tumors after endoscopic submucosal dissection including major papilla for laterally spreading ampullary tumors

    by Naohisa Yahagi, Teppei Akimoto, Yusaku Takatori, Motoki Sasaki, Kurato Miyazaki, Atsuto Kayashima, Teppei Masunaga, Kumiko Kirita, Mari Mizutani, Hiroki Tamagawa, et al.

    Endoscopic papillectomy (EP) enables resection of ampullary lesions but its use is limited by piecemeal resection and high recurrence rates. To overcome these limitations, we developed endoscopic submucosal dissection including papilla (ESDIP). This study aimed to evaluate clinical outcomes and identify risk factors for local residual/recurrent tumor after ESDIP for laterally spreading ampullary tumors. This single-center retrospective study analyzed consecutive patients who underwent ESDIP between 2011 and 2024. The primary outcome was local residual/recurrent tumor after ESDIP. Risk factors for local residual/recurrent tumor were evaluated using Cox proportional hazards regression analysis. Of the 81 consecutive patients in whom ESDIP was attempted, conversion to EP or surgery was done in 3. En bloc resection was achieved in all 78 remaining patients. After excluding 23 patients based on predefined criteria, 55 were analyzed. Median tumor size was 38 mm (range 15–128 mm). Negative horizontal and vertical margins, excluding the papillary ductal margin (PDM), were achieved in 48 patients (87%), whereas negative PDM and R0 resection were achieved in 34 (62%) and 29 (53%), respectively. Median follow-up was 31 months. The 3-year cumulative incidence of residual/recurrent tumor was 33%, and all residual/recurrent tumors were confined to the papilla. Positive/indeterminate PDM was a significant risk factor for local residual/recurrent tumor (hazard ratio 8.35, 95%CI 2.35–29.64). Although ESDIP enabled en bloc resection of laterally spreading ampullary tumors, the high rate of positive/indeterminate PDM, resulting in frequent papilla-confined residual/recurrent tumors, remained its main limitation.

  • Clinical Outcomes of Underwater Endoscopic Submucosal Dissection for Duodenal Tumors: A Systematic Review and Meta‐Analysis

    by Kumiko Kirita, Teppei Akimoto, Yasunori Sato, Motoki Sasaki, Maya Ishizawa, Mai Owada, Ai Katsumi, Yuki Kubo, Misaki Sugawara, Rei Mizobe, et al.

    Background and Study Aim: Underwater endoscopic submucosal dissection (U‐ESD) has recently been introduced as a technique that may improve visualization and submucosal layer expansion. However, the clinical outcomes of U‐ESD for duodenal tumors have not been systematically evaluated. This study aimed to assess the efficacy and safety of U‐ESD for duodenal tumors through a systematic review and meta‐analysis. Patients and Methods: A comprehensive literature search was conducted using PubMed, Scopus, and the Cochrane Library from database inception to December 12, 2025. Studies evaluating U‐ESD for duodenal tumors were included. Primary outcomes included en bloc resection, R0 resection, procedure time, adverse events, and complete mucosal defect closure. Pooled estimates were calculated using a random‐effects model. Results: Four retrospective studies comprising 298 lesions treated with U‐ESD were included. The pooled procedure time was 59 min (95% CI, 48–70 min; I 2 = 72%). The pooled en bloc resection rate was 99% (95% CI, 97%–100%; I 2 = 0%), and the pooled R0 resection rate was 89% (95% CI, 81%–93%; I 2 = 54%). The pooled intraoperative perforation rate was 5% (95% CI, 1%–23%; I 2 = 88%). The pooled delayed perforation and delayed bleeding rates were 1% (95% CI, 0%–3%; I 2 = 0%) and 2% (95% CI, 1%–5%; I 2 = 0%), respectively. Conclusion: Current evidence suggests that U‐ESD is a feasible treatment option for duodenal tumors and is associated with favorable clinical outcomes. However, the available evidence remains limited, and potential biases and concerns regarding generalizability warrant cautious interpretation of these findings.


  • A Novel Therapeutic Thin Endoscope Facilitates Gastric Endoscopic Submucosal Dissection in the Cardia and Pylorus: A Case Series Study (With Video)

    by Daisuke Minezaki, Teppei Masunaga, Motoki Sasaki, Shoma Murata, Yuri Imura, Anna Tojo, Hinako Sakurai, Kentaro Iwata, Kurato Miyazaki, Mari Mizutani, et al.

    Endoscopic submucosal dissection (ESD) is an established technique for treating superficial gastric neoplasms. However, performing ESD in the cardia and pylorus remains technically challenging due to the narrow lumens and steep angulations. Recently, a novel therapeutic thin endoscope, featuring a 7.9‐mm outer diameter, 160° downward angulation, 3.2‐mm working channel, and water jet function, was developed. We aimed to evaluate the feasibility of this novel endoscope for ESD in the cardia and pylorus. We retrospectively reviewed the data from gastric ESD cases in the cardia and pylorus using this novel endoscope at a single tertiary care center between March 2023 and September 2024. Clinical characteristics, procedural details, and treatment outcomes were analyzed. A total of 20 lesions (10 in the cardia, 10 in the pylorus) were included. The median lesion size was 15 mm (interquartile range: 10–30 mm). En bloc resection was successfully achieved in all cases without any adverse events. None of the cases required traction devices. Retroflexion was unnecessary in approximately half of the cases. In conclusion, this novel therapeutic thin endoscope facilitated en bloc resection without any adverse events in all cases; suggesting its feasibility for gastric ESD in anatomically complex regions characterized by narrow lumens and steep angulations.


  • Open Access

    Significance of Endoscopic Redness of Duodenum in Health Checkup

    by Atsushi Nakayama, Motohiko Kato, Yoshiki Sakaguchi, Yu Takahashi, Shinya Kodashima, Ai Fujimoto, Nobutake Yamamichi, Kazumasa Miki, Naohisa Yahagi

    Background and Aim: It is important for endoscopist to diagnose the lesion redness. In this study, we focused on the redness of duodenal bulb. We objectively analyzed the changes in redness of the duodenal bulb using linked color imaging (LCI) with chromatic indicators.Methods: Seven endoscopists observed the duodenal bulb with white light imaging (WLI) and LCI, and evaluated them by visual analogue scale (VAS) for the degree of redness. The difference in VAS between WLI and LCI was defined as ΔVAS. All images were quantified by the Comission Internationale de l'Eclariage‐L*a*b* color space. Values related to color differences (ΔE*, ΔL*, Δa*, and Δb*) were calculated from the two images of WLI and LCI. Multiple regression analysis was performed for the factors with the health checkup correlated with ΔVAS and the correlation between ΔVAS and ΔE*, ΔL*, Δa*, and Δb* was also examined.Results: The analysis prospectively included 1144 examinees. In multiple regression analysis, it revealed that sex (β = 0.5847, p < 0.0001) and metabolic syndrome (β = 0.4138, p = 0.0012) were the factors independently influenced ΔVAS. And only Δa*, a chromatic index for changes in the degree of redness, showed a statistically and considerably positive correlation with ΔVAS (r = 0.4529, p < 0.0001).Conclusion: To evaluate the difference in the degree of redness between WLI and LCI of duodenal bulb in esophagogastroduodenoscopy may help in early detection of metabolic syndrome, which rarely has symptoms.

  • Feasibility of endoscopic submucosal dissection including papilla (with video)

    by Naohisa Yahagi, Yusaku Takatori, Motoki Sasaki, Yuri Imura, Shoma Murata, Tsubasa Sato, Daisuke Minezaki, Takaoki Hayakawa, Yuki Nakajima, Haruka Okada, et al.

    Objectives: Endoscopic papillectomy (EP) is a low‐invasive treatment for duodenal tumors including papilla. The limit of lesion size and local recurrence have been issues in EP. We developed endoscopic submucosal dissection (ESD) for the duodenal tumors including papilla (ESDIP: ESD including papilla) to overcome the problems. The aim of this study was to evaluate the feasibility of ESDIP.Methods: We included the patients who underwent ESDIP from August 2010 to January 2024 in this study. We evaluated the retrospective characteristics of patients and lesions, clinical results of ESDIP and of endoscopic retrograde cholangiopancreatography (ERCP) as prevention for delayed adverse events, and pathological findings. We also calculated the cumulative recurrence rate and overall survival rate at 12 months after ESDIP.Results: Fifty‐four patients were included in this study. The mean lesion size was 39 mm. The third‐quarter cases revealed a less than half‐circumferential lesion, and the one case with a full‐circumferential lesion. Resection was accomplished in 96% (n = 52), and also the en‐bloc resection rate was 96%. Of the cases in accomplished resection, 98% of patients were intubated with a pancreaticobiliary drainage tube by ERCP. Intraprocedural perforation occurred in eight cases. Delayed bleeding occurred in 10 cases. Delayed perforation was seen only in one case. The incidence of post‐ERCP pancreatitis was 25%. Cumulative local recurrence rate and the overall survival rate were 15% and 96%, respectively.Conclusion: ESDIP may be feasible for duodenal tumors including papilla, and is a potential alternative option to avoid pancreaticoduodenectomy.


  • Novel perfusion system using continuous liquid‐suction catheter attachment in colorectal endoscopic submucosal dissection with water pressure method (with video)

    by Teppei Masunaga, Yusaku Takatori, Motoki Sasaki, Moe Sato, Daisuke Minezaki, Kohei Morioka, Anna Tojo, Hinako Sakurai, Kentaro Iwata, Kurato Miyazaki, et al.

    Water pressure method (WPM) is useful for colorectal endoscopic submucosal dissection (ESD), characterized not only by underwater conditions but also by active water pressure via the waterjet function. However, the extension of the colorectum by injecting excess water and contaminating the operative field by stool and bleeding have been issues. This study aimed to evaluate the feasibility of a novel perfusion system using a continuous liquid‐suction catheter attachment (CLCA) in colorectal ESD with WPM. We retrospectively reviewed cases in which the perfusion system was used in colorectal ESD with WPM between August 2022 and September 2023. We evaluated clinical characteristics, treatment outcomes, volume of injection by the waterjet function, volume of suction by the endoscope and CLCA, and concentration of floating matter in the operative field over time. Thirty‐one cases were enrolled. The median lesion size was 30 (range, 15–100) mm. In all cases, en bloc resection was achieved without perforation. The median injection volume was 2312 (range, 1234–13,866) g. The median suction volumes by the endoscope and CLCA were 918 (range, 141–3162) and 1147 (range, 254–11,222) g, respectively. The median concentration of floating matter in the operative field (measured in 15 cases) was 15.3 (range, 7.3–112) mg/mL when the endoscope arrived at the lesion and 8.0 (range, 3.2–16) mg/mL after endoscopically washing at the beginning of the ESD. It ranged from 7.6 to 13.4 mg/dL every 20 min during ESD. This perfusion system could prevent the extension of the lumen and maintain a good field of view in colorectal ESD with WPM.


  • Prospective cross‐organ analysis for the causes of fever and increased inflammatory response after endoscopic resection

    by Mari Mizutani, Daisuke Minesaki, Kohei Morioka, Kentaro Iwata, Kurato Miyazaki, Teppei Masunaga, Yoko Kubosawa, Yukie Hayashi, Motoki Sasaki, Teppei Akimoto, et al.

    Objectives: Fever and increased inflammatory responses sometimes occur following endoscopic resection (ER). However, the differences in causes according to the organ are scarcely understood, and several modified ER techniques have been proposed. Therefore, we conducted a comprehensive prospective study to investigate the cause of fever and increased inflammatory response across multiple organs after ER.Methods: We included patients who underwent gastrointestinal endoscopic submucosal dissection (ESD) and duodenal endoscopic mucosal resection at our hospital between January 2020 and April 2022. Primary endpoints were fever and increased C‐reactive protein (CRP) levels following ER. The secondary endpoints were risk factors for aspiration pneumonia. Blood tests and radiography were performed on the day after ER, and computed tomography was performed if the cause was unknown.Results: Among the 822 patients included, aspiration pneumonia was the most common cause of fever and increased CRP levels after ER of the upper gastrointestinal tract (esophagus, 53%; stomach, 48%; and duodenum, 71%). Post‐ER coagulation syndrome was most common after colorectal ESD (38%). On multivariate logistic regression analysis, lesions located in the esophagus (odds ratio [OR] 3.57; P < 0.001) and an amount of irrigation liquid of ≥1 L (OR 3.71; P = 0.003) were independent risk factors for aspiration pneumonia.Conclusions: Aspiration pneumonia was the most common cause of fever after upper gastrointestinal ER and post‐ER coagulation syndrome following colorectal ESD. Lesions in the esophagus and an amount of irrigation liquid of ≥1 L were independent risk factors for aspiration pneumonia.


  • Resectability of Small Duodenal Tumors: A Randomized Controlled Trial Comparing Underwater Endoscopic Mucosal Resection and Cold Snare Polypectomy

    by Kurato Miyazaki, Atsushi Nakayama, Motoki Sasaki, Daisuke Minezaki, Kohei Morioka, Kentaro Iwata, Teppei Masunaga, Yoko Kubosawa, Mari Mizutani, Yukie Hayashi, et al.

    INTRODUCTION: Underwater endoscopic mucosal resection (UEMR) and cold snare polypectomy (CSP) are novel endoscopic procedures for superficial nonampullary duodenal epithelial tumors (SNADET). However, consensus on how to use both procedures appropriately has not been established. In this study, we evaluated treatment outcomes of both procedures, including resectability. METHODS: In this single-center randomized controlled study conducted between January 2020 and June 2022, patients with SNADET ≤12 mm were randomly allocated to UEMR and CSP groups. The primary end point was sufficient vertical R0 resection (SVR0), which was defined as R0 resection including a sufficient submucosal layer. We compared treatment outcomes including SVR0 rate between groups. RESULTS: The SVR0 rate was significantly higher in the UEMR group than in the CSP group (65.6% vs 41.5%, P = 0.01). By contrast, the R0 resection rate was not significantly different between study groups (70.3% vs 61.5%, P = 0.29). The submucosal layer thickness was significantly greater in the UEMR group than in the CSP group (median 546 [range, 309–833] μm vs 69 [0–295] μm, P < 0.01). CSP had a shorter total procedure time (median 12 [range, 8–16] min vs 1 [1–3] min, P < 0.01) and fewer total bleeding events (9.4% vs 1.5%, P = 0.06). DISCUSSION: UEMR has superior vertical resectability compared with CSP, but CSP has a shorter procedure time and fewer bleeding events. Although CSP is preferable for most small SNADET, UEMR should be selected for lesions that cannot be definitively diagnosed as mucosal low-grade neoplasias.